Skip to main content

Tweets

We know most preexisting autoimmune disease is very mangaeable when checkpoint inhibitors are needed. So great to see that, in the VA, autoimmune disease pts largely haven't missed out on potentially lifesaving cancer immunotherapy. Keep on reassuring! #ACR24 ABST1985 @RheumNow https://t.co/ApOACBLi4K
David Liew @drdavidliew ( View Tweet )
1 week ago

Abst#1493 complete renal response (< 0.5 g/g w/< 10 mg/day pred); renal remission (UPCR < 0.3 g/g w/< 5 mg/day pred). 60 LN pts followed 3 yrs: 40% CRR & 19% RR. Pts not in CRR/RR had⬇️eGFR w/more decline in eGFR over time. No difference b/t CRR/ RR @rheumnow #ACRbest #ACR24

TheDaoIndex @KDAO2011 ( View Tweet )

1 week ago
I have no doubt many of our RA patients will take GLP-1 agonists in the future. Here's some data @UCLA showing significant differences in not just body weight and HbA1c, but pain. Will be fascinating to see what it does for grumbling disease activity! #ACR24 ABST2259 @RheumNow https://t.co/HdOPACEo3A
David Liew @drdavidliew ( View Tweet )
1 week ago
Renal biopsies, while painful, remain the gold standard for diagnosing and classifying lupus nephritis. But what if there are less-invasive methods? In this article, I highlight key abstracts exploring innovative approaches. https://t.co/ZInKmVS2Gn @RheumNow #ACR24

Akhil Sood MD @AkhilSoodMD ( View Tweet )

1 week ago
What is #healthliteracy? Why is it important for our patients with #RMDs? Come to poster 1913 today at #ACR24 to find out about health literacy & outcomes in #InflammatoryArthritis For more information on this important topic, read my article @RheumNow https://t.co/llWs5aYtpK

Mrinalini Dey @DrMiniDey ( View Tweet )

1 week ago
RheumNow’s expanded coverage of the #ACR24 meeting is sponsored in part by Novartis. All content is chosen by RheumNow & its faculty.

Dr. John Cush @RheumNow ( View Tweet )

1 week ago
Instead of just JAKi, why don't we look at all our RA meds and MACE risk FAERS data & reporting odds ratios here: all the caveats of voluntary reporting, so don't put too much weight, but... prednisone. Don't forget pred is really not great for MACE! #ACR24 ABST1981 @RheumNow https://t.co/L9SlPZF2Jd
David Liew @drdavidliew ( View Tweet )
1 week ago
Lung ultrasound for ILD in SSc/IIM would be great, no radiation and by the bedside - but a lot of skill required to interpret in reality. Maybe AI/computer vision can come to the rescue? Some nice models @StanfordRheum - will be watching this space! #ACR24 ABST1965 @RheumNow https://t.co/0uXBSVSE4c
David Liew @drdavidliew ( View Tweet )
1 week ago
"There's an app for that" but is it enough? US informatics national survey 2017-18: Rheum pts with digital health tools weren't any healthier living than those without (maybe helps exercise) It might be a conversation starter, but it's only an adjunct #ACR24 ABST1929 @RheumNow https://t.co/EZpSwm0zuP
David Liew @drdavidliew ( View Tweet )
1 week ago
Systemic polyarteritis nodosa looks creepily/scarily beautiful on PET/CT. Look at that Christmas tree! but sensitivity can be affected by pred, & isn't great even without (48%). By itself, a good rule in test, but not a good rule out test. #ACR24 ABST1962 @MayoClinic @RheumNow https://t.co/y28J6VKja4
David Liew @drdavidliew ( View Tweet )
1 week ago

Always looking for cancer/CV signals from JAKi in big observational datasets w extensive JAKi use nationwide 🇯🇵 claims data RA pts n=52k (JAKi n=4.3k) Cancer with JAKi vs TNFi: aHR 2.2 (esp lung, lymphoma) This is a problem. Watch these data. #ACR24 ABST1336 @RheumNow #ACRBest https://t.co/vsnT46De6T

David Liew @drdavidliew ( View Tweet )
1 week ago
Can you build systems that stop that ANA neg ENA pos anxiety? Plus $$? Lehigh Valley, Allentown, PA: lab would run ENA+dsDNA automatically, but only when ANA >1:80 (i.e. leave the ENA order to the lab) first voluntary, then compulsory it's possible! #ACR24 ABST1931 @RheumNow https://t.co/UQjWwve7DV
David Liew @drdavidliew ( View Tweet )
1 week ago